Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10015)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2013 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Respirology
ISSN
2218-6255
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Magkrioti C, Aidinis V. Autotaxin and lysophosphatidic acid signalling in lung pathophysiology. World J Respirol 2013; 3(3): 77-103 [DOI: 10.5320/wjr.v3.i3.77] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v3/i3/77.htm |
| Number | Citing Articles |
| 1 |
Amit Taneja, Garrit Jentsch, Stéphane Delage, Matthew J. Randall, Bernt van den Blink, Yasmina Bauer, Florence Namour. ISABELA Studies: Plasma Exposure and Target Engagement Do Not Explain the Lack of Efficacy of Ziritaxestat in Patients with Idiopathic Pulmonary Fibrosis. Clinical Pharmacology & Therapeutics 2024; 115(3): 606 doi: 10.1002/cpt.3138
|
| 2 |
Konstantinos Ntatsoulis, Theodoros Karampitsakos, Eliza Tsitoura, Elli-Anna Stylianaki, Alexios N. Matralis, Argyrios Tzouvelekis, Katerina Antoniou, Vassilis Aidinis. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.687397
|
| 3 |
Ioanna Nikitopoulou, Dionysios Fanidis, Konstantinos Ntatsoulis, Panagiotis Moulos, George Mpekoulis, Maria Evangelidou, Alice G. Vassiliou, Vasiliki Dimakopoulou, Edison Jahaj, Stamatios Tsipilis, Stylianos E. Orfanos, Ioanna Dimopoulou, Emmanouil Angelakis, Karolina Akinosoglou, Niki Vassilaki, Argyrios Tzouvelekis, Anastasia Kotanidou, Vassilis Aidinis. Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells. International Journal of Molecular Sciences 2021; 22(18): 10006 doi: 10.3390/ijms221810006
|
| 4 |
Qingling Li, Weng Wong, Andrew Birnberg, Arindam Chakrabarti, Xiaoying Yang, David F. Choy, Julie Olsson, Erik Verschueren, Margaret Neighbors, Wendy Sandoval, Carrie M. Rosenberger, Michele A. Grimbaldeston, Gaik W. Tew. Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease. BMC Pulmonary Medicine 2021; 21(1) doi: 10.1186/s12890-021-01670-9
|
| 5 |
Sara A. Knowlden, Sara E. Hillman, Timothy J. Chapman, Renukadevi Patil, Duane D. Miller, Gabor Tigyi, Steve N. Georas. Novel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation. American Journal of Respiratory Cell and Molecular Biology 2016; 54(3): 402 doi: 10.1165/rcmb.2015-0124OC
|
| 6 |
Jacopo Simonetti, Marco Ficili, Giacomo Sgalla, Luca Richeldi. Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Investigational Drugs 2024; 33(2): 133 doi: 10.1080/13543784.2024.2305126
|
| 7 |
Anand Balupuri, Myeong Hwi Lee, Sangeun Chae, Eunmi Jung, Woosub Yoon, Yunki Kim, So Jung Son, Jeonghee Ryu, Dae-Hyuck Kang, Young-Jae Yang, Ji-Na You, Hyunjin Kwon, Jong-Woo Jeong, Tae-Sung Koo, Dae-Yon Lee, Nam Sook Kang. Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation. European Journal of Medicinal Chemistry 2018; 148: 397 doi: 10.1016/j.ejmech.2018.02.049
|
| 8 |
Christiana Magkrioti, Nikos Oikonomou, Eleanna Kaffe, Marios-Angelos Mouratis, Nikos Xylourgidis, Iliana Barbayianni, Petros Megadoukas, Vaggelis Harokopos, Christos Valavanis, Jerold Chun, Alexandra Kosma, Georgios T. Stathopoulos, Evangelos Bouros, Demosthenes Bouros, Konstantinos Syrigos, Vassilis Aidinis. The Autotaxin—Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis. Cancer Research 2018; 78(13): 3634 doi: 10.1158/0008-5472.CAN-17-3797
|
| 9 |
Christiana Magkrioti, Eleanna Kaffe, Elli-Anna Stylianaki, Camelia Sidahmet, Georgia Melagraki, Antreas Afantitis, Alexios N. Matralis, Vassilis Aidinis. Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors. International Journal of Molecular Sciences 2020; 21(19): 7002 doi: 10.3390/ijms21197002
|
| 10 |
Efrosini Barbayianni, Eleanna Kaffe, Vassilis Aidinis, George Kokotos. Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer. Progress in Lipid Research 2015; 58: 76 doi: 10.1016/j.plipres.2015.02.001
|
| 11 |
Ioanna Ninou, Christiana Magkrioti, Vassilis Aidinis. Autotaxin in Pathophysiology and Pulmonary Fibrosis. Frontiers in Medicine 2018; 5 doi: 10.3389/fmed.2018.00180
|
| 12 |
Ioanna Nikitopoulou, Ioanna Ninou, Nikolaos Manitsopoulos, Ioanna Dimopoulou, Stylianos E. Orfanos, Vassilis Aidinis, Anastasia Kotanidou. A role for bronchial epithelial autotaxin in ventilator-induced lung injury. Intensive Care Medicine Experimental 2021; 9(1) doi: 10.1186/s40635-021-00379-7
|
| 13 |
Margaret Neighbors, Qingling Li, Sha (Joe) Zhu, Jia Liu, Weng Ruh Wong, Guiquan Jia, Wendy Sandoval, Gaik W. Tew. Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis. Journal of Lipid Research 2023; 64(6): 100375 doi: 10.1016/j.jlr.2023.100375
|
| 14 |
Marios-Angelos Mouratis, Christiana Magkrioti, Nikos Oikonomou, Aggeliki Katsifa, Glenn D. Prestwich, Eleanna Kaffe, Vassilis Aidinis, Xiao Su. Autotaxin and Endotoxin-Induced Acute Lung Injury. PLOS ONE 2015; 10(7): e0133619 doi: 10.1371/journal.pone.0133619
|
| 15 |
Christiana Magkrioti, Apostolos Galaris, Paraskevi Kanellopoulou, Elli-Anna Stylianaki, Eleanna Kaffe, Vassilis Aidinis. Autotaxin and chronic inflammatory diseases. Journal of Autoimmunity 2019; 104: 102327 doi: 10.1016/j.jaut.2019.102327
|